Recursion Pharmaceuticals vs Exa
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
Recursion Pharmaceuticals
Publicly traded techbio company (NASDAQ: RXRX) industrialising drug di...
Visit
|
Exa
Web search and retrieval API built for AI agents and apps
Visit
|
|
|---|---|---|
| RECATOOLS Score | 7 / 10 | 7.7 / 10 |
| Capability | — | |
| Value for money | — | |
| Ease of use | — | |
| ASEAN readiness | — | |
| API quality | — | |
| Pricing | Enterprise | Freemium |
| Free tier | — | 20,000 search requests per month on the free plan; startup and education grants of $1,000 in free API credits also available |
| Paid from | Partnership / collaboration deals (not a self-serve product) | API search billed at $7 per 1,000 requests (as of March 2026 pricing update) |
| Has API | ✗ | ✓ |
| Open source | ✗ | ✗ |
| Free to use | ✗ | ✓ |
| Users | — | — |
| Founded | 2013 | 2021 |
| Maker | Chris Gibson | — |
| Verdict | What this is for: AI-driven, industrial-scale drug discovery combining large biological datasets, automated experiments and its own supercomputing. Who this is for: Pharmaceutical and biotech partners, plus investors in... |
Exa earns its credibility through customer names, not just claims: Cursor, Notion AI, Cognition and OpenRouter all use it in production, and a $250M Series C at a $2.2B valuation (May 2026, led by a16z) backs that up. Th... |
| Full review → | Full review → |
← Back to AI Directory
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.